In vitro Susceptibility of Imipenem-resistant Pseudomonas aeruginosa against Piperacillin/tazobactam.
- Author:
Eui Chong KIM
1
Author Information
1. Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea. euichong@snu.ac.kr
- Publication Type:In Vitro ; Note
- Keywords:
Piperacillin/tazobactam;
Pseudomonas aeruginosa
- MeSH:
Imipenem;
Polymerase Chain Reaction;
Pseudomonas aeruginosa*;
Pseudomonas*
- From:Korean Journal of Clinical Microbiology
2007;10(2):171-172
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Minimal inhibitory concentrations (MICs) against piperacillin/tazobactam were determined on a total of 50 clinical isolates of imipenem resistant Pseudomonas aeruginosa (IRPA). MIC50 and MIC90 were 32microgram/mL and 512microgram/mL, respectively. The susceptibility of IRPA against piperacillin/tazobactam was 59%. Of the 50 IRPA strains, only two were PCR positive for blaVIM and none for blaIMP.
